Dewpoint has selected a novel small molecule to prevent the formation of abnormal TDP-43 protein clumps in ALS and other ...
Columnist Kristin Neva recalls a lesson from years ago about not giving in to "what ifs" as she contends with her husband's ...
A study suggests overactive VCP may contribute to ALS nerve damage by disrupting nuclear pore proteins in genetic ALS.
Mindwalk identified TDP-43 antibodies that selectively target abnormal protein clumps linked to ALS and other diseases.
Faced with stress and brain fog, columnist Juliet Taylor thought that staying on top of things would keep her husband's ALS ...
The first patient has been dosed in a Phase 2 clinical trial testing RAG-17 in people with ALS who carry mutations in the ...
Guest writer Anita Newton shares how she's been coping with grief in the years since her husband, Craig, passed away due to ALS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback